Mechanism of action of anticancer Vascular Disrupting Agents(VDAs)
Targeting enzymes in the tumor microenvironment: Cathepsin L and K inhibitors as anti-metastatic agents
Targeting enzymes in the tumor microenvironment: Enzymatic release of anticancer agents from protein-targeting-drug-linker conjugates
Targeting enzymes in the tumor microenvironment: Bioreductive activation of prodrugs
(*Significant Collaboration with The Pinney Research Group, Baylor University)